By Matt Fates, Partner and Jeff Knox, Associate Summary The last two decades have seen tremendous expansion of biological datasets and...

Summary In drug development, new molecular entities get all the press. That’s largely justified – new molecules mean new medicines and...

Even before Generative AI caught fire, computationally aided drug discovery was an area of intense interest for researchers. It should...